Artículos con índice de calidad relativo

1. Vicente E, Nuñez-Alfonsel J, Ielpo B, Ferri V, Caruso R, Duran H, Diaz E, Malave L, Fabra I, Pinna E, Isernia R, Hidalgo A, Quijano Y. A cost-effectiveness analysis of robotic versus laparoscopic distal pancreatectomy. The International Journal of Medical Robotics and Computer Assisted Surgery 2020; e2080. https://doi.org/10.1002/rcs.2080
2. Quijano Y, Nuñez-Alfonsel J, Ielpo B, Ferri V, Caruso R, Durán H, Díaz E, Malavé L, Fabra I, Pinna E, Isernia R, Hidalgo A, Vicente E. Robotic versus laparoscopic surgery for rectal cancer: a comparative cost-effectiveness study. Springer Nature Switzerland AG (2020) https://doi.org/10.1007/s10151-020-02151-7
3. Merino M, Jiménez M, Manito N, Casariego E, Ivanova Y, González-Domínguez A, San Saturnino M, Hidalgo-Vega A, Blanch C. The social return on investment of a new approach to heart failure in the Spanish National Health System. ESC Heart Failure (2020) DOI: 10.1002/ehf2.12535
4. la Plaza Llamas, de, R., Hidalgo-Vega, Á., Latorre Fragua, R. A., Lopez Marcano, A. J., Medina Velasco, A. A., Diaz Candelas, D. A., et al. (2019). The Cost of Postoperative Complications and Economic Validation of the Comprehensive Complication Index: Prospective Study. Annals of Surgery. http://doi.org/10.1097/SLA.0000000000003308
5. Merino M, Villoro R, Hidalgo-Vega A, Carmona C, Collaborative Working Group E-E. Health-related quality of life of patients diagnosed with COPD in Extremadura, Spain: results from an observational study. Health Qual Life Outcomes. 2019;17(1):189.¶
6. Ielpo B., Nuñez-Alfonsel J., Diago MV., Hidalgo A., Quijano Y., Vicente E. The issue of the cost of robotic distal pancreatectomies. Hepatobiliary Surg Nutr 2019, 8(6):655-658. doi: 10.21037/hbsn.2019.09.23
7. Santacruz-Salas E, Aranda-Reneo I, Hidalgo-Vega Á, Blanco-Rodriguez JM, Segura-Fragoso A. The Economic Influence of Breastfeeding on the Health Cost of Newborns. Journal of Human Lactation. 2019; 35(2), 340–348.
8. Garrido-Cumbrera M, Navarro-Compan V, Zarco P, et al. Atlas of Axial Spondyloarthritis in Spain 2017: Study Design and Population. Reumatol Clin. 2019; 15(3):127-132
9. Hidalgo-Vega Á, Martell N, Orozco-Beltrán D, Galgo A, Muñiz O, Górriz JL, Ferrer-Vidal N, Sabaté N and Merino M. Herramienta para mejorar la eficiencia en el manejo clínico de pacientes hipertensos. Hipertensión y Riesgo Vascular. 2019; 36(2):70-84
10. Delgado-Ortega L, González-Domínguez A, Borrás JM, Oliva-Moreno J, González-Haba E, Menjón S, Pérez P, Vicente D, Cordero L, Jiménez M, Simón S, Hidalgo-Vega A, Moya-Alarcón C. The Economic Burden of Disease of Epithelial Ovarian Cancer in Spain. The Ovarcost Study. The European Journal of Health Economics. 2019; 20(1), 135-147
11. Mestre-Ferrandiz J, Zozaya N, Alcala B, Hidalgo-Vega A. Multi-Indication Pricing: Nice in Theory but Can it Work in Practice? Pharmacoeconomics. 2018;36(12):1407-1420.
12. Merino M, Villoro R, Hidalgo-Vega A and Carmona C. Social economic costs of chronic obstructive pulmonary disease in Extremadura (Spain): an observational study. International Journal of Chronic Obstructive Pulmonary Disease. Volume 2018(13):2501-2514
13. Zozaya N, Martínez-Galdeano L, Alcalá B, Armario-Hita JC, Carmona C, Carrascosa JM, Herranz P, Lamas MJ, Trapero-Bertran M, Hidalgo-Vega A. Determining the Value of Two Biologic Drugs for Chronic Inflammatory Skin Diseases: Results of a Multi-Criteria Decision Analysis. BioDrugs. 2018;32(3):281-291.
14. Busutil R, Espallardo O, Torres A, Martinez-Galdeano L, Zozaya N, Hidalgo-Vega A. The impact of obesity on health-related quality of life in Spain. Health Qual Life Outcomes. 2017;15(1):197. p.1 – p.11
15. Espallardo O, Busutil R, Torres A, Zozaya N, Villoro R, Hidalgo-Vega A. The Impact of Severe Obesity on Healthcare Resource Utilisation in Spain. Obes Surg. 2017; 27(8):2058-2066
16. Garcia-Soidan FJ, Villoro R, Merino M, Hidalgo-Vega A, Hernando-Martin T Gonzalez-Martin-Moro B. [Health status, quality of life, and use of healthcare resources by patients with diabetes mellitus in Spain]. Semergen. 2017. 43(6):416-424
17. Villoro R, Merino M, Hidalgo-Vega A, Jimenez M, Martinez L, Aracil J. Women with urinary incontinence in Spain: Health-related quality of life and the use of healthcare resources. Maturitas. 2016;94:52-7.
18. Ene G, Garcia Raso A, Gonzalez-Dominguez A, Hidalgo-Vega A, Llamas P. Cost of vitamin K antagonist anticoagulant treatment in patients with metallic prosthetic valve in mitral position. SAGE Open Med. 2016;4:1-7.
19. Perez de Llano LA, Villoro R, Merino M, Gomez Neira MD, Muniz C, Hidalgo A. Cost Effectiveness of Outpatient Asthma Clinics. Arch Bronconeumol. 2016: 52(4):196-203.
20. Hidalgo-Vega, A., Villoro, R., Blasco, J. A., Talavera, P., Ferro, B. & Purcaru, O. 2015. Cost-utility analysis of certolizumab pegol versus alternative tumour necrosis factor inhibitors available for the treatment of moderate-to-severe active rheumatoid arthritis in Spain. Cost Eff Resour Alloc, 2015(13), 11.
21. Espín Balbino J, Brosa Riestra M, Oliva J, Trapero-Bertran M, Flores S, Figueras M, Garcia-Mochón L, Hidalgo-Vega A, Poveda JL, Rovira J Sánchez F. Cuestiones controvertidas en evaluación económica (III): la evaluación económica de intervenciones sanitarias en tres situaciones especiales: enfermedades raras, los tratamientos al final de la vida y las externalidades en las evaluaciones. Rev Esp Salud Pública 2015; 89: 237-247.
22. Peña-Longobardo LM, Oliva-Moreno J, Hidalgo-Vega Á, Miravitlles M: Economic valuation and determinants of informal care to disabled people with Chronic Obstructive Pulmonary Disease (COPD). BMC Health Services Research 2015, 15(101). p.1-p.7
23. Oliva-Moreno J, Peña-Longobardo LM, Alonso S, Fernández-Bolaños A, Gutiérrez ML, Hidalgo-Vega A, de la Fuente E, Fernández-Rodríguez CM Labour productivity losses caused by premature death associated with hepatitis C in Spain. European Journal of Gastroenterology Hepatology. 2015; 27(6): 631-637.
24. Miravitlles M, Peña-Longobardo LM, Oliva-Moreno J, Hidalgo-Vega A. Caregivers’ burden in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease. 2015;10(1):347—356.
25. Hidalgo-Vega A, Ramos-Goni JM, Villoro R. Cost-utility of ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Spain. The European journal of health economics: HEPAC. health economics in prevention and care. 2014;Dec;15(9):917-925.
26. Hidalgo-Vega A, Askari E, Vidal R, et al. Direct vitamin k antagonist anticoagulant treatment health care costs in patients with non-valvular atrial fibrillation. BMC health services research. Jan 30 2014;14(1):46
27. Hidalgo A, Viloro R, Ivanova A, Morell A, Talavera P, Ferro B. Tratamiento biológico de la artritis reumatoide en España. Análisis de impacto presupuestario de la utilización de certolizumabpegol. PharmacoEconomics Spanish Research Articles. 2014;11(3):97-107.
28. Cabello Granado P, Hidalgo Vega A. Análisis de la eficiencia hospitalaria por comunidad autónoma en el ámbito del Sistema Nacional de Salud. Investigaciones Regionales. 2014;28:147-158.
29. Sanz-Granda A, Hidalgo A, del Llano JE, Rovira J. Analysis of economic evaluations of pharmacological cancer treatments in Spain between 1990 and 2010. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. Jan 2013;15(1):9-19.
30. Oliva-Moreno J, Aranda-Reneo I, Vilaplana-Prieto C, Gonzalez-Dominguez A, Hidalgo-Vega A. Economic valuation of informal care in cerebrovascular accident survivors in Spain. BMC health services research. 2013;13:508.
31. Cortes I, Perez-Camarero S, Del Llano J, Pena LM, Hidalgo-Vega A. Systematic review of economic evaluation analyses of available vaccines in Spain from 1990 to 2012. Vaccine. Aug 2 2013;31(35):3473-3484.
32. Aranda-Reneo I, Oliva-Moreno J, Vilaplana-Prieto C, Hidalgo-Vega A, Gonzalez-Dominguez A. Informal Care of Patients with Schizophrenia. J Ment Health Policy. Sep 2013;16(3):99-108.
33. Vano-Galvan, S., et al., [Analysis of the cost effectiveness of home-based phototherapy with narrow-band UV-B radiation compared with biological drugs for the treatment of moderate to severe psoriasis]. Actas Dermosifiliogr, 2012. 103(2): p. 127-137.
34. Oliva, J., A. Fernandez-Bolanos, and A. Hidalgo, Health-related quality of life in diabetic people with different vascular risk. BMC Public Health, 2012. 12:812. p.1 – p.8
35. Vano-Galvan, S., et al., [Store-and-forward teledermatology: assessment of validity in a series of 2000 observations]. Actas Dermosifiliogr, 2011. 102(4): p. 277-83.
36. Hidalgo, A. and G.D. Pintos, The National Health System in Spain: The impact of regulatory reforms on health care. Medicine and Law, 2009. 28(1): p. 47-69.
37. Rodriguez-Roca, G.C., et al., Cost-effectiveness of ambulatory blood pressure monitoring in the follow-up of hypertension. Blood Press, 2006. 15(1): p. 27-36.